Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1997;76(6):819–826. doi: 10.1038/bjc.1997.468

Photodynamic therapy as adjuvant therapy in surgically treated pleural malignancies.

P Baas 1, L Murrer 1, F A Zoetmulder 1, F A Stewart 1, H B Ris 1, N van Zandwijk 1, J L Peterse 1, E J Rutgers 1
PMCID: PMC2228043  PMID: 9310252

Abstract

Five patients with a pleural malignancy (four malignant mesotheliomas and one localized low grade carcinoid) were treated with maximal surgical resection of the tumour followed by intraoperative adjuvant photodynamic therapy (PDT). The additional photodynamic treatment was performed with light of 652 nm from a high power diode laser, and meta-tetrahydroxy phenylchlorin as the photosensitizer. The light delivery to the thoracic cavity was monitored by in situ isotropic light detectors. The position of the light delivery fibre was adjusted to achieve optimal light distribution, taking account of reflected and scattered light in this hollow cavity. There was no 30-day post-operative mortality and only one patient suffered from a major complication (diaphragmatic rupture and haematopericardium). The operation time was increased by a maximum of 1 h to illuminate the total hemithoracic surface with 10 J cm(-2) (incident and scattered light). The effect of the adjuvant PDT was monitored by examination of biopsies taken 24 h after surgery under thoracoscopic guidance. Significant damage, including necrosis, was observed in the marker lesions with remaining malignancy compared with normal tissue samples, which showed only an infiltration with PMN cells and oedema of the striated muscles cells. Of the five patients treated, four are alive with no signs of recurrent tumour with a follow-up of 9-11 months. One patient was diagnosed as having a tumour dissemination in the skin around the thoracoscopy scar and died of abdominal tumour spread. Light delivery to large surfaces for adjuvant PDT is feasible in a relatively short period of time (< 1 h). In situ dosimetry ensures optimal light distribution and allows total doses (incident plus scattered light) to be monitored at different positions within the cavity. This combination of light delivery and dosimetry is well suited for adjuvant treatment with PDT in malignant pleural tumours.

Full text

PDF
819

Images in this article

821Figure 1
on p.821
824Figure 4
on p.824

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Butchart E. G., Gibbs A. R. Pleural mesothelioma. Curr Opin Oncol. 1990 Apr;2(2):352–358. doi: 10.1097/00001622-199004000-00018. [DOI] [PubMed] [Google Scholar]
  2. Chahinian A. P., Antman K., Goutsou M., Corson J. M., Suzuki Y., Modeas C., Herndon J. E., 2nd, Aisner J., Ellison R. R., Leone L. Randomized phase II trial of cisplatin with mitomycin or doxorubicin for malignant mesothelioma by the Cancer and Leukemia Group B. J Clin Oncol. 1993 Aug;11(8):1559–1565. doi: 10.1200/JCO.1993.11.8.1559. [DOI] [PubMed] [Google Scholar]
  3. Chahinian A. P., Pajak T. F., Holland J. F., Norton L., Ambinder R. M., Mandel E. M. Diffuse malignant mesothelioma. Prospective evaluation of 69 patients. Ann Intern Med. 1982 Jun;96(6 Pt 1):746–755. doi: 10.7326/0003-4819-96-6-746. [DOI] [PubMed] [Google Scholar]
  4. DaValle M. J., Faber L. P., Kittle C. F., Jensik R. J. Extrapleural pneumonectomy for diffuse, malignant mesothelioma. Ann Thorac Surg. 1986 Dec;42(6):612–618. doi: 10.1016/s0003-4975(10)64593-6. [DOI] [PubMed] [Google Scholar]
  5. Lira-Puerto V., Silva A., Morris M., Martinez R., Groshen S., Morales-Canfield F., Tenorio F., Muggia F. Phase II trial of carboplatin or iproplatin in cervical cancer. Cancer Chemother Pharmacol. 1991;28(5):391–396. doi: 10.1007/BF00685695. [DOI] [PubMed] [Google Scholar]
  6. Lofgren L., Larsson M., Thaning L., Hallgren S. Transthoracic endoscopic photodynamic treatment of malignant mesothelioma. Lancet. 1991 Feb 9;337(8737):359–359. doi: 10.1016/0140-6736(91)90983-v. [DOI] [PubMed] [Google Scholar]
  7. Marijnissen J. P., Star W. M. Calibration of isotropic light dosimetry probes based on scattering bulbs in clear media. Phys Med Biol. 1996 Jul;41(7):1191–1208. doi: 10.1088/0031-9155/41/7/008. [DOI] [PubMed] [Google Scholar]
  8. Pass H. I., DeLaney T. F., Tochner Z., Smith P. E., Temeck B. K., Pogrebniak H. W., Kranda K. C., Russo A., Friauf W. S., Cole J. W. Intrapleural photodynamic therapy: results of a phase I trial. Ann Surg Oncol. 1994 Jan;1(1):28–37. doi: 10.1007/BF02303538. [DOI] [PubMed] [Google Scholar]
  9. Ris H. B., Altermatt H. J., Inderbitzi R., Hess R., Nachbur B., Stewart J. C., Wang Q., Lim C. K., Bonnett R., Berenbaum M. C. Photodynamic therapy with chlorins for diffuse malignant mesothelioma: initial clinical results. Br J Cancer. 1991 Dec;64(6):1116–1120. doi: 10.1038/bjc.1991.474. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Ris H. B., Altermatt H. J., Nachbur B., Stewart C. M., Wang Q., Lim C. K., Bonnett R., Althaus U. Intraoperative photodynamic therapy with m-tetrahydroxyphenylchlorin for chest malignancies. Lasers Surg Med. 1996;18(1):39–45. doi: 10.1002/(SICI)1096-9101(1996)18:1<39::AID-LSM5>3.0.CO;2-S. [DOI] [PubMed] [Google Scholar]
  11. Rusch V., Saltz L., Venkatraman E., Ginsberg R., McCormack P., Burt M., Markman M., Kelsen D. A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma. J Clin Oncol. 1994 Jun;12(6):1156–1163. doi: 10.1200/JCO.1994.12.6.1156. [DOI] [PubMed] [Google Scholar]
  12. Sugarbaker D. J., Heher E. C., Lee T. H., Couper G., Mentzer S., Corson J. M., Collins J. J., Jr, Shemin R., Pugatch R., Weissman L. Extrapleural pneumonectomy, chemotherapy, and radiotherapy in the treatment of diffuse malignant pleural mesothelioma. J Thorac Cardiovasc Surg. 1991 Jul;102(1):10–15. [PubMed] [Google Scholar]
  13. Sørensen P. G., Bach F., Bork E., Hansen H. H. Randomized trial of doxorubicin versus cyclophosphamide in diffuse malignant pleural mesothelioma. Cancer Treat Rep. 1985 Dec;69(12):1431–1432. [PubMed] [Google Scholar]
  14. Takita H., Mang T. S., Loewen G. M., Antkowiak J. G., Raghavan D., Grajek J. R., Dougherty T. J. Operation and intracavitary photodynamic therapy for malignant pleural mesothelioma: a phase II study. Ann Thorac Surg. 1994 Oct;58(4):995–998. doi: 10.1016/0003-4975(94)90443-x. [DOI] [PubMed] [Google Scholar]
  15. van Staveren H. J., Beek J. F., Ramaekers J. W., Keijzer M., Star W. M. Integrating sphere effect in whole bladder wall photodynamic therapy: I. 532 nm versus 630 nm optical irradiation. Phys Med Biol. 1994 Jun;39(6):947–959. doi: 10.1088/0031-9155/39/6/003. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES